Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome | Zendy

Moore Alexandra | Zendy; Burrows Amanda K. | Zendy; Malik Richard | Zendy; Ghubash Rudayna M. | Zendy; Last Robert D. | Zendy; Remaj Benjamin | Zendy

Premium

Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome

Author(s) -

Moore Alexandra,

Burrows Amanda K.,

Malik Richard,

Ghubash Rudayna M.,

Last Robert D.,

Remaj Benjamin

Publication year - 2022

Publication title -

veterinary dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.744

H-Index - 60

eISSN - 1365-3164

pISSN - 0959-4493

DOI - 10.1111/vde.13097

Subject(s) - feline immunodeficiency virus , toxoplasmosis , toxoplasma gondii , medicine , virology , cats , protozoan parasite , human immunodeficiency virus (hiv) , immunology , lentivirus , viral disease , antibody , parasite hosting , world wide web , computer science

Toxoplasma gondii is a ubiquitous protozoan, for which felids are the definitive host. Immunocompromised individuals are susceptible to recrudescent toxoplasmosis. This case describes a 6‐year‐old, feline immunodeficiency virus‐positive domestic short hair cat with feline atopic skin syndrome that developed fatal toxoplasmosis after treatment with oclacitinib for five months.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research